经进一步改进后，应用从病人身上切除的肿瘤组织细胞加IL-2在体外培养,诱导并扩增出TIL（肿瘤浸润的淋巴细胞），它的杀肿瘤活性比LAK细胞强100倍，输回病人后，可获得更好的疗效。
基于62个网页-相关网页
肿瘤浸润的淋巴细胞（tumor infiltrating lymphocyte,TIL）是 继LAK 细胞之后的第二代抗肿瘤效应细胞，能够特异性杀伤肿瘤细胞， 抗肿瘤活性较LAK 细胞强5...
基于10个网页-相关网页
为肿瘤浸润的淋巴细胞 tumor infiltrating lymphocyte
目的探讨卵巢癌组织中肿瘤浸润淋巴细胞(TIL)的分布及临床意义。
Objective To investigate the distribution of tumor-infiltrating lymphocytes (TIL) in the epithelial ovarian carcinoma (EOC) and its clinical significance.
目的探讨白细胞介素（IL） 2与IL 4对膀胱癌肿瘤浸润性淋巴细胞（TIL）体外增殖及细胞毒性免疫调控的协同作用。
Objective To investigate the synergy effects of IL 2 and IL 4 on the proliferation and cytotoxicity of tumor infiltrating lymphocytes (TIL) from murine bladder carcinoma in vitro.
目的：探讨致敏的树突状细胞（DC）激活的肿瘤浸润淋巴细胞（TIL）体外抗小鼠乳腺癌活性。
Objective: To investigate the activities of tumor infiltrating lymphocytes(TILs) stimulated by dendritic cells(DCs) on mouse breast cancer cells in vitro.
应用推荐